NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.789
-0.054 (-6.43%)
At close: Mar 9, 2026, 4:00 PM EDT
0.788
-0.001 (-0.06%)
After-hours: Mar 9, 2026, 5:49 PM EDT
NMTC Revenue
NeuroOne Medical Technologies had revenue of $2.89M in the quarter ending December 31, 2025, a decrease of -11.65%. This brings the company's revenue in the last twelve months to $11.72M, up 103.78% year-over-year. In the fiscal year ending September 30, 2025, NeuroOne Medical Technologies had annual revenue of $12.10M with 250.35% growth.
Revenue (ttm)
$11.72M
Revenue Growth
+103.78%
P/S Ratio
3.31
Revenue / Employee
$650,898
Employees
18
Market Cap
39.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 12.10M | 8.64M | 250.35% |
| Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
| Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
| Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
| Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Outset Medical | 119.48M |
| TELA Bio | 77.06M |
| Myomo | 41.64M |
| Cytosorbents | 36.98M |
| electroCore | 29.84M |
| Spectral AI | 23.17M |
| Elutia | 21.75M |
NMTC News
- 20 days ago - NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - NeuroOne Medical Technologies Corporation - Special Call - Seeking Alpha
- 6 months ago - NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 - GlobeNewsWire
- 7 months ago - NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain - GlobeNewsWire
- 7 months ago - NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% - GlobeNewsWire
- 7 months ago - NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update - GlobeNewsWire